arrow
I

Ivette Cruz-Bautista

instituto nacional de ciencias médicas y nutricion salvador zubiran
H指数:26
被引数:3,239

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lessons from single cell omics: admixed American ancestry and sex confer cardiometabolic disease risk in Mexicans

单细胞组学的研究启示:混血美洲血统和性别会增加墨西哥人的心血管代谢疾病风险

2026-03-280
OAAI
Lp(a) Testing in Latin America: Low Awareness and Clinicalpractice Among Medical Society Physicians Highlight a Missed Opportunity in Cardiovascular Prevention

Lp(a)检测在拉丁美洲:低认知度和临床实践在医学协会医师中凸显心血管预防方面的错失良机

2025-12-220
PRE
Impaired Cardiorespiratory Fitness in Type 1 Diabetes Is Associated With Metabolic Inflexibility and Specific Factors According to Sex

1型糖尿病中心血管呼吸功能受损与代谢适应性及性别特异性因素相关

2025-12-140
OAAI
Association of pro-inflammatory and anti-inflammatory cytokine polymorphisms with COVID-19 severity in unvaccinated patients

未接种疫苗患者中促炎和抗炎细胞因子多态性与COVID-19严重程度的相关性

2025-08-130
OA
Lipoprotein (a) levels and clinical decision-making: data from a Mexican cohort at a tertiary medical institution

脂蛋白(a)水平与临床决策制定:来自一家三级医疗机构的墨西哥队列数据

2025-05-260
OA
Transcriptional dynamics in type 2 diabetes progression is linked with circadian, thermogenic, and cellular stress in human adipose tissue (vol 8, 398, 2025)

转录动态与2型糖尿病进展相关,并与人类脂肪组织中的昼夜节律、产热和细胞应激有关(卷8,398,2025)

2025-04-010
OA
Distribution of triglyceride-rich lipoproteins and their remnants and their contribution to cardiovascular risk in the Mexican population

甘油三酯富集脂蛋白及其残粒的分布及其在墨西哥人群中心血管风险的贡献

2024-05-210
PRE
Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia
2021-02-158
OAAI
Physiological Network From Anthropometric and Blood Test Biomarkers
2021-01-129
OAAI
Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach
2020-07-2249
OAAI
Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health

内脏脂肪代谢评分 (METS-VF),腹内脂肪含量和心脏代谢健康的新估计量

2020-05-0172
PREAI
The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes
2019-02-0119
OA